In a groundbreaking study, scientists from Skoltech, Switzerland, and China have successfully integrated MRI, ultrasound, and optoacoustics into a universal contrast agent. This injectable drug has the potential to revolutionize medical diagnostics by significantly improving the speed, accuracy, and cost-effectiveness of examinations.
Biomedical imaging plays a crucial role in enabling physicians and researchers to visualize the structure and function of living tissues, leading to the diagnosis and treatment of diseases. Currently, ultrasound and MRI scans are the most commonly used techniques for radiation-free imaging. However, optoacoustics, a promising emerging approach, has only recently been introduced into clinical practice.
The research team achieved the integration of these three distinct imaging techniques by developing a unique contrast agent in the form of loaded microbubbles. These microbubbles were created using a layer-by-layer deposition technique and were loaded with indocyanine green dye and magnetite nanoparticles. The dye enables the absorption of light and the emission of detectable sound waves, which is how optoacoustics functions. Meanwhile, the magnetite nanoparticles enhance contrast during MRI exams. The microbubbles themselves serve as a contrast agent for ultrasound studies, with the added benefit of increased stability due to their liquid-filled core.
Experiments conducted on mice confirmed that the microbubbles exhibited contrast in all three modes of medical imaging. Additionally, cytotoxicity tests demonstrated that the contrast agent is biocompatible, ensuring its safe application. By combining the individual advantages of each imaging technique, the researchers were able to achieve higher sensitivity, improved imaging resolution, and reduced invasiveness. Previously, multiple injections were required for each imaging technique, but with the universal contrast agent, only one injection is now needed.
The potential applications of this innovative contrast agent extend beyond diagnostics. The microbubbles have the potential to deliver drugs into the brain, making them particularly valuable in treating patients with Parkinson’s or tumors. The team’s research also suggests that these microbubbles can be used in magnetic resonance and optoacoustic imaging of the brain. Normally, the “blood-brain barrier” restricts the entry of molecules and contrast agents into the brain. However, the team’s multifunctional contrast agent can open the blood-brain barrier using focused ultrasound on microbubbles, reducing the harm to surrounding tissue. This technique allows for a single injection to suffice for a brain exam while extending circulation.
The liquid-core microbubbles offer several advantages over conventional gas-core microbubbles, including enhanced stability and prolonged resistance to ultrasound exposure. This characteristic allows the barrier to remain open for longer periods, reducing the dosage of the contrast agent required in the injection.
Furthermore, the researchers propose the integration of therapeutic agents using the same layer-by-layer deposition approach. This allows for MRI-guided minimally invasive treatment, known as theranostics, which opens up new possibilities for treating glioblastoma, the most aggressive and common type of brain cancer.
In summary, the development of this universal contrast agent marks a significant advancement in the field of medical imaging. With its ability to combine MRI, ultrasound, and optoacoustics into a single injection, this contrast agent has the potential to transform the way medical exams are conducted. By improving imaging resolution, reducing invasiveness, and enabling targeted drug delivery, this innovation could have a profound impact on disease diagnosis and treatment in the future.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc.